Cargando…

Recombinant Antibodies to the Ebola Virus Glycoprotein

Currently, there are no approved therapies for targeted prevention and treatment of Ebola hemorrhagic fever. In the present work, we describe the development of a eukaryotic expression system for the production of three full-length chimeric antibodies (IgG1-kappa isotypes) GPE118, GPE325, and GPE534...

Descripción completa

Detalles Bibliográficos
Autores principales:	Panina, A. A., Dementieva, I. G., Aliev, T. K., Toporova, V. A., Balabashin, D. S., Bokov, M. N., Pozdnyakova, L. P., Shchemchukova, O. B., Dolgikh, D. A., Sveshnikov, P. G., Kirpichnikov, M. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	A.I. Gordeyev 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762832/ https://www.ncbi.nlm.nih.gov/pubmed/29340221

Ejemplares similares

Recombinant Bispecific Antibodies to the Human ErbB2 Receptor and Interferon-Beta
por: Panina, A. A., et al.
Publicado: (2020)

The Development and Study of Recombinant Immunoglobulin A to Hemagglutinins of the Influenza Virus
por: Aliev, T. K., et al.
Publicado: (2018)

Optimization of recombinant antibody production based on the vector design and the level of metabolites for generation of Ig- producing stable cell lines
por: Toporova, V. A., et al.
Publicado: (2023)

Bispecific Antibodies for IFN-β Delivery to ErbB2(+) Tumors
por: Rybchenko, Vladislav S., et al.
Publicado: (2021)

Targeted Cytokine Delivery for Cancer Treatment: Engineering and Biological Effects
por: Rybchenko, Vladislav S., et al.
Publicado: (2023)

Conformational Differences between Active Angiotensins and Their Inactive Precursors
por: Solopova, O.N., et al.
Publicado: (2012)

Antibody Derived Peptides for Detection of Ebola Virus Glycoprotein
por: Rodríguez-Martínez, Luis Mario, et al.
Publicado: (2015)

Toremifene interacts with and destabilizes the Ebola virus glycoprotein
por: Zhao, Yuguang, et al.
Publicado: (2016)

Selection, characterization, and thermal stabilization of llama single domain antibodies towards Ebola virus glycoprotein
por: Liu, Jinny L., et al.
Publicado: (2017)

Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies
por: Steeds, Kimberley, et al.
Publicado: (2020)

Purification and characterization of monoclonal IgG antibodies recognizing Ebola virus glycoprotein
por: Han, Baek-Sang, et al.
Publicado: (2018)

An exploration of conditions proposed to trigger the Ebola virus glycoprotein for fusion
por: Fénéant, Lucie, et al.
Publicado: (2019)

An immunotoxin targeting Ebola virus glycoprotein inhibits Ebola virus production from infected cells
por: Cai, Yingyun, et al.
Publicado: (2021)

Transient Liver Damage and Hemolysis Are Associated With an Inhibition of Ebola Virus Glycoprotein-Specific Antibody Response and Lymphopenia
por: Fausther-Bovendo, Hugues, et al.
Publicado: (2021)

Interferon-Induced HERC5 Inhibits Ebola Virus Particle Production and Is Antagonized by Ebola Glycoprotein
por: Paparisto, Ermela, et al.
Publicado: (2021)

Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection
por: Marzi, Andrea, et al.
Publicado: (2016)

Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site
por: Howell, Katie A., et al.
Publicado: (2016)

Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013–2016 Epidemic
por: Diehl, William E., et al.
Publicado: (2016)

Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing
por: Shrivastava-Ranjan, Punya, et al.
Publicado: (2018)

The Ebola Virus Glycoprotein Contributes to but Is Not Sufficient for Virulence In Vivo
por: Groseth, Allison, et al.
Publicado: (2012)

Ebola Virus Glycoprotein Domains Associated with Protective Efficacy
por: Bhatia, Bharti, et al.
Publicado: (2021)

Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection
por: Iampietro, Mathieu, et al.
Publicado: (2017)

Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone
por: Manno, Daniela, et al.
Publicado: (2022)

BROADLY NEUTRALIZING ANTIBODIES FROM HUMAN SURVIVORS TARGET A CONSERVED SITE IN THE EBOLA VIRUS GLYCOPROTEIN HR2/MPER REGION
por: Flyak, Andrew I., et al.
Publicado: (2018)

Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates
por: Gunn, Bronwyn M., et al.
Publicado: (2023)

Effect of Gamma Irradiation on the Antibody Response Measured in Human Serum from Subjects Vaccinated with Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Envelope Glycoprotein Vaccine
por: Grant-Klein, Rebecca J., et al.
Publicado: (2019)

Comparative Analysis of Ebola Virus Glycoprotein Interactions With Human and Bat Cells
por: Kühl, Annika, et al.
Publicado: (2011)

Ebola virus glycoprotein stimulates IL-18–dependent natural killer cell responses
por: Wagstaffe, Helen R., et al.
Publicado: (2020)

Antiviral protection by antibodies targeting the glycan cap of Ebola virus glycoprotein requires activation of the complement system
por: Bukreyev, Alexander, et al.
Publicado: (2023)

BoHV-4-based vector delivering Ebola virus surface glycoprotein
por: Rosamilia, Alfonso, et al.
Publicado: (2016)

Recombinant RNA-Dependent RNA Polymerase Complex of Ebola Virus
por: Tchesnokov, Egor P., et al.
Publicado: (2018)

Involvement of Surfactant Protein D in Ebola Virus Infection Enhancement via Glycoprotein Interaction
por: Favier, Anne-Laure, et al.
Publicado: (2018)

In silico-based vaccine design against Ebola virus glycoprotein
por: Dash, Raju, et al.
Publicado: (2017)

Ebola Virus Glycoprotein Induces an Innate Immune Response In vivo via TLR4
por: Lai, Chih-Yun, et al.
Publicado: (2017)

High-affinity recombinant phage antibodies to the pan-carcinoma marker epithelial glycoprotein-2 for tumour targeting.
por: Roovers, R. C., et al.
Publicado: (1998)

Targeting Extracellular Vesicles to Dendritic Cells and Macrophages
por: Ovchinnikova, L. A., et al.
Publicado: (2021)

Successful post-exposure prophylaxis of Ebola infected non-human primates using Ebola glycoprotein-specific equine IgG
por: Pyankov, Oleg V., et al.
Publicado: (2017)

The Ebola-Glycoprotein Modulates the Function of Natural Killer Cells
por: Edri, Avishay, et al.
Publicado: (2018)

Atypical Ebola Virus Disease in a Nonhuman Primate following Monoclonal Antibody Treatment Is Associated with Glycoprotein Mutations within the Fusion Loop
por: Banadyga, Logan, et al.
Publicado: (2021)

Recombinant Sudan virus and evaluation of humoral cross-reactivity between Ebola and Sudan virus glycoproteins after infection or rVSV-ΔG-ZEBOV-GP vaccination
por: Kainulainen, Markus H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_remt1mp4uc2njfhndr1ts5o3t2